HAL (France)
open access
Emicizumab and shared medical decision in patients living with hemophilia A
Aim: Emicizumab is a new prophylactic treatment for patients with severe hemophilia A. This study evaluated patient decisional conflict and physician decisional comfort regarding the switch to emicizumab, identifying the criteria that drive this choice. Methods: This is an observational, non-interve
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Emicizumab and shared medical decision in patients living with hemophilia A.#923640
- An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors#28479
- Emicizumab in Patients With Acquired Hemophilia A#915496
- Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A#1101747
- Factor IX as Adjunctive Therapy to Emicizumab (EMIX)#892818
Record · ID 1203604
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive